Literature for peptidase C01.075: cruzipain

Summary Alignment Sequences Sequence features Distribution Structure Literature Substrates Inhibitors Pharma

(References are filtered for relevance to Structure. To remove the filter click here. See explanation.)

    2019
  1. Barbosa da Silva,E., Dall,E., Briza,P., Brandstetter,H. and Ferreira,R.S.
    Cruzain structures: apocruzain and cruzain bound to S-methyl thiomethanesulfonate and implications for drug design
    Acta Crystallogr F Struct Biol Commun (2019) 75, 419-427. PubMed  Europe PubMed DOI  S
  2. 2018
  3. Giroud,M., Dietzel,U., Anselm,L., Banner,D., Kuglstatter,A., Benz,J., Blanc,J.B., Gaufreteau,D., Liu,H., Lin,X., Stich,A., Kuhn,B., Schuler,F., Kaiser,M., Brun,R., Schirmeister,T., Kisker,C., Diederich,F. and Haap,W.
    Repurposing a library of human cathepsin L ligands: identification of macrocyclic lactams as potent rhodesain and Trypanosoma brucei inhibitors
    J Med Chem (2018) 61, 3350-3369. PubMed  Europe PubMed DOI  S  I
  4. 2013
  5. Assis,D.M., Gontijo,V.S., de Oliveira Pereira,I., Santos,J.A., Camps,I., Nagem,T.J., Ellena,J., Izidoro,M.A., Dos Santos Tersariol,I.L., de Barros,N.M., Doriguetto,A.C., Dos Santos,M.H. and Juliano,M.A.
    Inhibition of cysteine proteases by a natural biflavone: behavioral evaluation of fukugetin as papain and cruzain inhibitor
    J Enzyme Inhib Med Chem (2013) 28, 661-670. PubMed  Europe PubMed DOI  S  I
  6. 2012
  7. Lee,G.M., Balouch,E., Goetz,D.H., Lazic,A., McKerrow,J.H. and Craik,C.S.
    Mapping inhibitor binding modes on an active cysteine protease via nuclear magnetic resonance spectroscopy
    Biochemistry (2012) 51, 10087-10098. PubMed  Europe PubMed DOI  E  S  I
  8. 2010
  9. Mott,B.T., Ferreira,R.S., Simeonov,A., Jadhav,A., Ang,K.K., Leister,W., Shen,M., Silveira,J.T., Doyle,P.S., Arkin,M.R., McKerrow,J.H., Inglese,J., Austin,C.P., Thomas,C.J., Shoichet,B.K. and Maloney,D.J.
    Identification and optimization of inhibitors of trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB
    J Med Chem (2010) 53, 52-60. PubMed  Europe PubMed DOI  S  I
  10. 2009
  11. Bryant,C., Kerr,I.D., Debnath,M., Ang,K.K., Ratnam,J., Ferreira,R.S., Jaishankar,P., Zhao,D., Arkin,M.R., McKerrow,J.H., Brinen,L.S. and Renslo,A.R.
    Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases
    Bioorg Med Chem Lett (2009) 19, 6218-6221. PubMed  Europe PubMed DOI  S  I
  12. Kerr,I.D., Lee,J.H., Farady,C.J., Marion,R., Rickert,M., Sajid,M., Pandey,K.C., Caffrey,C.R., Legac,J., Hansell,E., McKerrow,J.H., Craik,C.S., Rosenthal,P.J. and Brinen,L.S.
    Vinyl sulfones as antiparasitic agents and a structural basis for drug design
    J Biol Chem (2009) 284, 25697-25703. PubMed  Europe PubMed DOI  PMC  EPMC  S  I
  13. 2005
  14. [YEAR:15-3-2005]Choe,Y., Brinen,L.S., Price,M.S., Engel,J.C., Lange,M., Grisostomi,C., Weston,S.G., Pallai,P.V., Cheng,H., Hardy,L.W., Hartsough,D.S., McMakin,M., Tilton,R.F., Baldino,C.M. and Craik,C.S.
    Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease
    Bioorg Med Chem (15-3-2005) 13, 2141-2156. PubMed  Europe PubMed DOI  S  I
  15. 2003
  16. Huang,L., Brinen,L.S. and Ellman,J.A.
    Crystal structures of reversible ketone-based inhibitors of the cysteine protease cruzain
    Bioorg Med Chem (2003) 11, 21-29. PubMed  Europe PubMed DOI  S  I
  17. 1997
  18. Gillmor,S.A., Craik,C.S. and Fletterick,R.J.
    Structural determinants of specificity in the cysteine protease cruzain
    Protein Sci (1997) 6, 1603-1611. PubMed  Europe PubMed DOI  PMC  EPMC  S  I
  19. 1995
  20. McGrath,M.E., Eakin,A.E., Engel,J.C., McKerrow,J.H., Craik,C.S. and Fletterick,R.J.
    The crystal structure of cruzain: A therapeutic target for Chagas' disease
    J Mol Biol (1995) 247, 251-259. PubMed  Europe PubMed DOI  S